PATENT CLAIM ANALYSIS

Application Number: 16090144
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["546", "064000"]

Abstract:
The disclosure provides new, stable, pharmaceutically acceptable salt forms of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Claim (Index 1):
A salt of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3\u2032,4\u2032:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one (ITI-007), wherein the salt is selected from the oxalate, the 4-aminosalicylate, and the cyclamate.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12922056', '14177689', '14954845', '15234053', '16142514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6883610987033638
- 35 USC 102 Novelty (BERT): 0.4427821118013511
- Combined Prediction Score: 0.6638032000131625
- Mean Citation Score: 108.42357920000002
- Max Citation Score: 113.82308
- Similarity Product: 96.77749096425536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test